Thyroid Hormone Synthesis and TRH-TSH Axis
The hypothalamic-pituitary-thyroid (HPT) axis: TRH (thyrotropin-releasing hormone) from paraventricular nucleus drives TSH (thyrotropin) from anterior pituitary thyrotrophs. TSH binds TSHR (a Gs-coupled GPCR) on thyroid follicular cells, activating cAMP/PKA to stimulate: NIS (sodium-iodide symporter, SLC5A5) for iodide uptake, thyroid peroxidase (TPO) for iodination of thyroglobulin Tyr residues, and thyroglobulin proteolysis releasing T4 (thyroxine, 3,5,3-prime,5-prime-tetraiodothyronine) and T3 (triiodothyronine, 3,5,3-prime-triiodothyronine). T4 (90% of secretion) is the prohormone; peripheral deiodinases convert it to active T3.
Deiodinases: T4 to T3 Conversion
Three selenoprotein deiodinases regulate T3 availability: DIO1 (liver, kidney, selenocysteine Sec at active site, Km ~1 microM T4, outer-ring and inner-ring deiodinase), DIO2 (brain, pituitary, brown adipose, outer-ring only, local T3 production, Km ~1 nM T4), and DIO3 (inner-ring deiodinase producing reverse T3 rT3 and T2, thyroid hormone inactivation, placenta/fetal). DIO2 is critical for local T3 generation in brain and BAT; its expression is regulated by TSH, cAMP, and NRF2 (ARE in DIO2 promoter). Selenium adequacy (supported by spirulina's selenomethionine and Sec biosynthesis support) is essential for DIO1/2/3 catalytic function.
TRalpha and TRbeta: Nuclear Receptor Isoforms
Thyroid hormone receptors (TR-alpha/NR1A1 and TR-beta/NR1A2) are ligand-activated nuclear receptors binding T3 (Kd ~0.2 nM). TRalpha1 is predominant in heart, skeletal muscle, bone, and brain; TRbeta1 in liver and kidney; TRbeta2 in pituitary (for T3 negative feedback on TSH). TR-RXR heterodimers bind thyroid response elements (TREs, DR4: RGKTCA separated by 4 bp) or palindromes. Without T3, TRs recruit corepressors (NCoR/SMRT, HDAC3) suppressing basal transcription; T3 binding dissociates corepressors and recruits coactivators (SRC-1/NCOA1, CBP/p300, TRAP/ Mediator) for transcriptional activation.
Thyroid Hormone and Mitochondrial Biogenesis
T3 is a potent inducer of mitochondrial biogenesis and OXPHOS: TRalpha directly transactivates PGC-1alpha, NRF1, TFAM, and OXPHOS complex subunits including cytochrome c oxidase (COX) subunits. T3 also increases UCP1 in BAT (via TRalpha on the UCP1 TRE), driving thermogenesis. At the mitochondrial level, T3 directly enters mitochondria and stimulates mitochondrial transcription factor function independently of nuclear TR. Spirulina's PGC-1alpha induction via AMPK/SIRT1 is mechanistically convergent with T3 effects on mitochondrial biogenesis, providing complementary activation of the same gene network.
Thyroid Hormone and Lipid/Cholesterol Metabolism
TRbeta1 in liver drives LDLR transcription (reducing LDL), increases cholesterol bile acid conversion (CYP7A1, CYP7B1), and regulates hepatic fatty acid oxidation (ACAD, CPT1A). Hypothyroidism leads to hypercholesterolaemia (reduced LDLR). TRbeta1 agonists (eprotirome, sobetirome) are explored for LDL reduction without TRalpha- mediated cardiac effects. Spirulina's lipid-lowering effects (LDLR preservation via PCSK9/AMPK/HMGCR mechanisms) are mechanistically parallel to TRbeta1 outputs, suggesting spirulina may complement thyroid hormone in lipid management.
Thyroid Function and Spirulina Evidence
Some studies in iodine-deficient or hypothyroid animal models report spirulina modestly increases T3/T4 levels, possibly through selenium support of DIO activity and iodine content in spirulina biomass (~100-200 microg/100g DW depending on growth medium). The NF-kB-thyroid connection is also relevant: NF-kB suppresses TRH transcription under inflammatory conditions (sick euthyroid/non-thyroidal illness syndrome). Spirulina's NF-kB suppression may preserve TRH-TSH-thyroid axis function during inflammation-driven hypothyroidism.
Related Reading
Get the weekly digest
Curated science, recipes, and brand intel — once a week, no spam, unsubscribe in one click.